An observational study to determine the prognostic factors for uveitis in patients with behcet's Disease who were treated with infliximab.

Trial Profile

An observational study to determine the prognostic factors for uveitis in patients with behcet's Disease who were treated with infliximab.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2015

At a glance

  • Drugs Infliximab (Primary)
  • Indications Behcet's syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top